Oss, Netherlands

Maria Lourdes Ollero

This inventor holds 2 USPTO granted patents. Top assignee: N.v. Organon. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Lourdes Ollero. Retrieved from https://idiyas.com/inventor/maria-lourdes-ollero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maria Lourdes Ollero: Innovator in Progesterone Receptor Modulators

Introduction

Maria Lourdes Ollero is a prominent inventor based in Oss, Netherlands. She has made significant contributions to the field of pharmacology, particularly in the development of progesterone receptor modulators. With a total of 2 patents to her name, Ollero's work is paving the way for advancements in medical treatments.

Latest Patents

Ollero's latest patents focus on innovative progesterone receptor modulators. The first patent presents new modulators that are dibenzo[b,f]pyrido[1,2-d]oxazepine-2-amines or dibenzo[b,f]pyrido[1,2-d]thiazepine-2-amines, along with their various uses. The second patent introduces (cis)-8-fluorodibenzo[b,f]pyrido[1,2-d]oxazepine-1-amine compounds, which also have significant applications in the medical field.

Career Highlights

Maria Lourdes Ollero is currently employed at N.V. Organon, a company known for its focus on women's health and innovative therapies. Her work at Organon has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Ollero collaborates with esteemed colleagues such as Johannes Bernardus Maria Rewinkel and Brigitte Johanna Bernita Folmer. These partnerships enhance the research efforts and innovation within her field.

Conclusion

Maria Lourdes Ollero is a key figure in the development of progesterone receptor modulators, with her patents reflecting her commitment to advancing medical science. Her contributions at N.V. Organon and collaborations with fellow researchers underscore her impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…